Investments, Funding & Disinvestment

Under the renewed agreement, Bora will provide end-to-end manufacturing services for more than 20 commercial GSK product lines.

The procedures took place at Al-Nasr Specialised Hospital in Port Said, representing a major advancement in accessible cardiac care for Egyptian citizens.

Novartis will continue operating its subsidiary Novartis Healthcare Private Limited, which serves as the commercial arm for the company’s operations in India.

The acquisition centers on anitocabtagene autoleucel, known as anito-cel, an investigational CAR-T cell therapy targeting multiple myeloma.

The pharmaceutical giant will pay Frontier USD 40 million upfront, with additional payments of up to USD 963 million tied to achieving specific development, regulatory, and commercial milestones.

These investments aim to elevate the standard of care available to patients while positioning Alameda as a provider of choice for complex medical procedures.

The partnership forms a cornerstone of “Plan Mexico,” a government-led economic growth strategy designed to attract investment and develop domestic manufacturing capabilities.

Through this collaboration, they will tackle healthcare projects from multiple angles, offering services that span consulting, strategic planning, feasibility assessments, and market and financial studies.

The move positions DHCC as a healthcare destination that’s actively adapting to global shifts in how medical care is delivered and customized.

The announcement comes as part of Dubai’s Economic Agenda D33, which aims to position the emirate as a global healthcare destination.